These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3487322)

  • 1. Effect of anti-T cell autoantibodies from systemic lupus erythematosus sera upon T lymphocyte functions.
    Goldschmidt LP; Kresina TF; Kammer GM
    Arthritis Rheum; 1986 May; 29(5):646-54. PubMed ID: 3487322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature of IgG anti-lymphocyte autoantibody-reactive molecules shed from activated T cells in systemic lupus erythematosus.
    Minota S; Winfield JB
    Rheumatol Int; 1988; 8(4):165-70. PubMed ID: 3055216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus. Evidence for a disorder intrinsic to the T lymphocyte.
    Kammer GM
    J Clin Invest; 1983 Nov; 72(5):1686-97. PubMed ID: 6355184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line.
    Minota S; Winfield JB
    J Immunol; 1987 Mar; 138(6):1750-6. PubMed ID: 3102598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
    Minota S; Winfield JB
    J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
    Litvin DA; Cohen PL; Winfield JB
    J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus.
    Winfield JB; Shaw M; Minota S
    J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.
    Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC
    J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
    Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-type specificity of anti-CD45 autoantibodies in systemic lupus erythematosus.
    Czyzyk J; Fernsten P; Shaw M; Winfield JB
    Arthritis Rheum; 1996 Apr; 39(4):592-9. PubMed ID: 8630107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus sera inhibit antigen presentation by macrophages to T cells.
    Brozek CM; Hoffman CL; Savage SM; Searles RP
    Clin Immunol Immunopathol; 1988 Feb; 46(2):299-313. PubMed ID: 3257427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.
    Morimoto C; Reinherz EL; Distaso JA; Steinberg AD; Schlossman SF
    J Clin Invest; 1984 Mar; 73(3):689-700. PubMed ID: 6231307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-lymphocyte antibodies in systemic lupus erythematosus and in Hodgkin's disease: a comparison by immunofluorescence.
    Del Giacco GS; Leone AL; Locci F; Manconi PE; Tognella S; Mantovani G; Grifoni V
    Biomedicine; 1976 May; 25(3):79-80. PubMed ID: 779861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of T cell mediated regulation of anti-DNA production in systemic lupus erythematosus.
    Clough JD; Frank SA; Calabrese LH
    Arthritis Rheum; 1980 Jan; 23(1):24-9. PubMed ID: 6965452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus. Relationship to a defective cAMP pathway.
    Kammer GM; Mitchell E
    Arthritis Rheum; 1988 Jan; 31(1):88-98. PubMed ID: 2830891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.